Copertina

Can imiquimod really provoke psoriasis?

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Katinka Ónodi, Eszter Baltas
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	International Journal of Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Successful treatment of alopecia areata‐associated trachyonychia with baricitinib
di: Petra Rózsa, et al.
Pubblicazione: (2024)

Erythema Annulare Centrifugum Following PD ‐1 Inhibitor Therapy in Melanoma: A Case Report
di: Leticia Szadai, et al.
Pubblicazione: (2026)

Body Dysmorphic Disorder, Social Media Use, Borderline and Narcissistic Pathologies
di: Eszter Szlávicz, et al.
Pubblicazione: (2025)

Targeting the NLRP3 inflammasome in psoriasis
di: Xiuhui Chen, et al.
Pubblicazione: (2024)

The use of upadacitinib to successfully treat eczematized psoriasis
di: Kazuki Yatsuzuka, et al.
Pubblicazione: (2024)

Dermoscopic features of nail psoriasis: a systematic review
di: Hanane Rachadi, et al.
Pubblicazione: (2024)

Biologic therapy increases Demodex density in psoriasis patients
di: Hasan Aksoy, et al.
Pubblicazione: (2024)

Lasers for the treatment of nail psoriasis: a systematic review
di: Dana Jaalouk, et al.
Pubblicazione: (2024)

Tralokinumab‐induced psoriasis relapse in a patient with atopic dermatitis
di: Alessandra Chiei Gallo, et al.
Pubblicazione: (2024)

Disparities and barriers to the access of biologics in moderate‐to‐severe adult psoriasis
di: Vincent Wan, et al.
Pubblicazione: (2024)

Tissue‐resident memory T cells in a psoriatic lesion on a scar: comparison of a continuous lesion of psoriasis, psoriasis with a scar, and non‐lesional skin
di: Masato Ishikawa, et al.
Pubblicazione: (2024)

Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series
di: Calvo‐Asín Carlos, et al.
Pubblicazione: (2024)

Frequency of use and annual costs of biological therapy for psoriasis in Colombia in 2019
di: Daniel G. Fernández‐Ávila, et al.
Pubblicazione: (2024)

Association of hematological ratios with psoriasis: a nationwide retrospective cohort study
di: Sarah Weissmann, et al.
Pubblicazione: (2024)

Prevalence of anxiety and depression symptoms among patients with psoriasis in Kabul, Afghanistan
di: Ahmad Khalid Aalemi, et al.
Pubblicazione: (2024)

Experience of living with psoriasis in Brazil: a Global Psoriasis Atlas online survey
di: Jaquelini Barboza da Silva, et al.
Pubblicazione: (2024)

Narcissistic Traits and Narcissistic Personality Disorder in Dermatology With a Focus on Body‐Dysmorphic Disorder
di: Eszter Szlávicz, et al.
Pubblicazione: (2026)

Drug survival, effectiveness, and safety of brodalumab for moderate‐to‐severe psoriasis up to 3 years
di: Luca Mastorino, et al.
Pubblicazione: (2024)

Single‐center experience with bimekizumab in psoriasis patients with previous exposure to interleukin‐17 inhibitors
di: Ioannis‐Alexios Koumprentziotis, et al.
Pubblicazione: (2024)

Rapid resolution of guttate psoriasis without recurrence for one year following two doses of guselkumab
di: Carlota Abbad‐Jaime de Aragón, et al.
Pubblicazione: (2024)

Risk factors and early detection of joint damage in patients with psoriasis: a case–control study
di: Amin Yao, et al.
Pubblicazione: (2024)

A randomized trial comparing 308 nm excimer light with PUVA soak therapy for palmoplantar psoriasis
di: Mohammad Danish, et al.
Pubblicazione: (2024)

Multi‐failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort
di: Riccardo Viola, et al.
Pubblicazione: (2024)

Impact of psoriasis on the risk of device‐related infective endocarditis in patients with permanent pacemakers: a propensity‐matched analysis
di: Chapman Wei, et al.
Pubblicazione: (2024)

Validation of the Peak Pruritus‐Numerical Rating Scale in patients with chronic plaque psoriasis: results from a phase 2 study
di: Zoe D. Draelos, et al.
Pubblicazione: (2024)

Psoriasis dermatitis, a common phenotype of early forms of both psoriasis and atopic dermatitis in children: A prospective multicenter study
di: Alexandre Docampo‐Simón, et al.
Pubblicazione: (2024)

Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group
di: Antonio Sahuquillo‐Torralba, et al.
Pubblicazione: (2024)

Letter in response to “Psoriasis dermatitis, a common phenotype of early forms of both psoriasis and atopic dermatitis in children: a prospective multicenter study”
di: Avik Mondal, et al.
Pubblicazione: (2024)

Rapid and sustained resolution in generalized pustular psoriasis with IL‐17A inhibitors required high adherence: a 96‐week analysis in a real‐life setting
di: Kun Hu, et al.
Pubblicazione: (2024)

Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
di: Esteban Daudén, et al.
Pubblicazione: (2024)

Can't Judge a Book by Its Cover: An Unusual Case of Orbital Swelling
di: Cristina Sarda, et al.
Pubblicazione: (2025)

Artificial Intelligence and Trichoscopy: Can AI Distinguish Between Alopecia Areata and Lichen Planopilaris?
di: Daniele Omar Traini, et al.
Pubblicazione: (2026)

Umbilical psoriasis is not relevant to psoriatic arthritis
di: Maki Takada, et al.
Pubblicazione: (2024)

Sclerosing cholangitis exacerbated by widespread pustular psoriasis
di: Akane Ogaya, et al.
Pubblicazione: (2024)

Systemic therapy for psoriasis and the risk of cutaneous infections
di: Yuko Higashi, et al.
Pubblicazione: (2024)

Regional differences in the prevalence of generalized pustular psoriasis in Japan
di: Hideki Fujita, et al.
Pubblicazione: (2024)

Effective management of coexisting bullous pemphigoid and psoriasis with bimekizumab
di: Ken Okamura, et al.
Pubblicazione: (2024)

Predictive factors for responders to deucravacitinib treatment in patients with psoriasis
di: Teppei Hagino, et al.
Pubblicazione: (2024)

Use of PPE gowns to avoid scabies infestation and a 3‐day ivermectin therapy to reduce risk of spread of contagion
di: Craig G. Burkhart
Pubblicazione: (2024)

Isotretinoin as a promising option in the treatment of facial papules of frontal fibrosing alopecia
di: Amir Mohammad Beyzaee, et al.
Pubblicazione: (2024)